The Food and Drug Administration (FDA) on March 17 published a final guidance on reprocessing reusable medical devices. This guidance, which provides manufacturers with recommendations to validate their reprocessing instructions, comes on the heels of a host of “superbug” bacteria outbreaks related to reprocessing of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes.
Left sniffling and sneezing after a whirlwind 4 days at…
Approximately one in 31 hospital patients has at least one…
From integrating new technology to navigating shifts in care delivery…